Navigation Links
Biolistic Transfection of Organotypic Brain Slices

he fine processes of the neurons in these slices. Using this method of visualization, even the axons of transfected neurons were visualized for millimeters across the slice, terminating in clearly defined growth cones (Lo et al., 1994).


Discussion
A number of factors affect the success of Biolistic transfection in a given tissue (see Methods and Results above and Sanford et al., 1993 for a more comprehensive review). These parameters must be optimized for each cell and tissue type, and controls must be designed to ensure that bombardment process is not causing cell or tissue damage. For organotypic brain slices, the most important parameter is culture health. If slices are unhealthy for any reason, levels of transfection will be reduced. Once the specific parameters of the Biolistic transfection are optimized for a particular tissue type, the method itself is quite reliable and reproducible. More often than not, if no transfected cells are obtained, it is the health of the cultures that is the problem.

Successful transfection of neuronal cell lines can be achieved with a fairly wide range of Biolistic parameters. The transfection rate of these cells is very reliable, even for co-transfection of multiple plasmids. While transfection rates vary according to the density of cells plated, the amount of gold used in each blast, the efficiency of the expression construct, the exact blasting pressure, the amount of vaccuum pulled, and protecting the cells from the shock of the blast do not seem to be crucial for successful transfection of cell lines.


Summary
We have shown that Biolistic bombardment can be reliably used to transfect neurona
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Using the VersaFluor Fluorometer to Quantitate GUS Expression in Plant Tissues Bombarded With the Biolistic PDS-1000/He System
2. Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A
3. Comparison of Performance Characteristics of Different Biolistic Devices
4. Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System
5. Sub-Micron Gold Particles Are Superior to Larger Particles for Efficient Biolistic Transformation of Organelles and Some Cells
6. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
7. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
10. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
11. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biolistic Transfection Organotypic Brain Slices

(Date:11/6/2009)...Y., Nov. 6 BioSpecifics ...utical company developing first-in-class collagena...esults for the third quarter ended September 30, 2...ember of this year, the FDA,s Arthritis Advisory C...0, the approval of XIAFLEX(TM) for the treatment o...
(Date:11/6/2009)...Y, Calif., Nov. 6 Calbiotech, Inc....Business Innovative Research (SBIR) Phase I contra...command. Under terms of the agreement, Calbiotech ...the diagnosis of Dengue virus. ,, Dengue vir... major threat to military forces deployed to tropi...
(Date:11/5/2009)..., Md., Nov. 5 GenVec, In...results for the third quarter ended September 30, ...$0.04 per share) for the three months ended Septem...n ($0.08 per share) in the comparable quarter of 2... GenVec,s net loss was $14.1 million ($0.15 per sh...
(Date:11/5/2009)...all on Thursday, November 5, 2009 at 4:30 p.m. Eas.../PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals...XI ) today reported unaudited financial results fo...r 30, 2009 and reviewed the Company,s highlights f...consolidated results reflect the operations of Onc...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...Boston-based interactive marketing and Web develop...ebsite for Anika Therapeutics - www.anikatherapeu...ops products that address the fast-growing joint h...adhesion markets. The company worked with Pixel Br...w site. , Boston, MA (PRW...
... of Standards and Technology (NIST) and the Joint ... the University of Maryland and NIST, have reporte...ntum dots by manipulating them with pairs of laser...Letters ,* could significantly improve quantum dot...perty with important applications in quantum infor...
...ident and CEO,of the Pharmagistics Group, the prem...delivered messages and solutions for the biopharma...E magazine as one of the 100 most,inspiring and in...gistics,Group is a suite of four companies within ...e honor was announced in the July/August issue of ...
Other Biology Technology:Pixel Bridge Works With Anika Therapeutics to Launch New Website 2Pixel Bridge Works With Anika Therapeutics to Launch New Website 3Light touch: Controlling the behavior of quantum dots 2Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences 2Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences 3
(Date:11/5/2009)..., The National Association of Biology Teachers (N...r of biological sciences at Naugatuck Valley Commu...h the 2009 Evolution Education Award during the NA...e held 11-14 November 2009 in Denver, Colorado. ,...the American Institute of Biological Sciences,(AI...
(Date:11/4/2009)..., Heavy traffic corridors in the cities of Long B...nt proportion of preventable childhood asthma, and...ns on the disease has likely been underestimated, ...hern California (USC). , The study, which appea...f Public Health , estimated that nine percent of a...
(Date:11/4/2009)..., PORTOLA VALLEY, Calif., Oct. 19 /PRNewswire...ced molecular sensing and imaging devices which sh...oday that it has signed exclusive distribution dea...nd Sensors. The markets covered include Australia...rg (Benelux), Suriname, Italy, France, Spain, Port...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USC study finds big air pollution impacts on local communities 2Spectros Signs New International Distribution Deals 2Medical ethics experts identify address key issues in H1N1 pandemic 58211 1Medical ethics experts identify address key issues in H1N1 pandemic 58211 2Medical ethics experts identify address key issues in H1N1 pandemic 58211 3Medical ethics experts identify address key issues in H1N1 pandemic 58211 4Medical ethics experts identify address key issues in H1N1 pandemic 58211 5Medical ethics experts identify address key issues in H1N1 pandemic 58211 6Medical ethics experts identify address key issues in H1N1 pandemic 58211 7Medical ethics experts identify address key issues in H1N1 pandemic 58211 8Medical ethics experts identify address key issues in H1N1 pandemic 58211 9Physicists at UC Santa Barbara make discovery in quantum mechanics 14243 1Physicists at UC Santa Barbara make discovery in quantum mechanics 14243 2Governor Howard Dean to Discuss Health Care Reform at Philadelphia and New York City Book Signing Appearances 58207 1
...ich are typically used as anti-cholesterol medicat... C virus (HCV). They could replace ribavirin in co...are published in the July 2006 issue of Hepatology... for the Study of Liver Diseases (AASLD). Publishe...ailable online via Wiley InterScience at http://w...
...uch as monkeys which have exceptionally large brai...e study, carried out by Dr Susanne Shultz, from th...ors from Africa and South America such as the jagu...that prey with a small brain such as small antelop...ptible to attacks by predators compared with large...
... display a dramatic reduction of cancer-causing ge...vate the expression of protective microRNAs in the...e June issue of Cancer Cell, demonstrates that age...act regulatory RNAs that may function as tumor sup...tegy for treating human cancers. , DNA methylation...
Other Biology News:Statins stop hepatitis C virus from replicating 2Activation of microRNA inhibits cancer gene in human cancer cells 2
Goat Anti-ZBP-89 (S-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Enolase from baker's yeast (S. cerevisiae) from Sigma-Aldrich
UNOsphere S Support, 100 ml from Bio-Rad
Baker's yeast (S. cerevisiae) Phosphoglucose isomerase from Sigma-Aldrich
Biology Products: